Business Intelligence & Analytics for the New Age

May 8, 2020

Register now Traditional insight communication methods are ineffective and costly. Clients waste millions of dollars each year in building new report and dashboard assets, yet these assets have an average active lifespan of only 3 – 6 months.  No wonder clients complain about swimming in an ocean but are still thirsty for water – they […]

Failure to Start: Filling the cracks COVID exposed in patient onboarding support to enable successful new therapy initiations in an uncertain world

May 7, 2020

Register now COVID social distancing policies revealed cracks in our support system for training and onboarding patients onto biologic therapies. Heavy reliance on HCPs and in-person training support failed patients during the pandemic. As a result, many patients hoping to start therapy delayed relief, and recent starts were asked to slow down their loading doses. […]

The Critical Importance of ePRO (electronic Patient Reported Outcomes) in Clinical Research in Our Challenging and Evolving Time

April 27, 2020

Register now You will want to attend this virtual panel bringing together leaders in clinical development/operations and data management. This expert panel is currently deeply engaged in complex global ePRO studies. The panel will discuss: The critical importance of ePRO/eCOA data in today’s clinical research Managing critical end-points in ePRO data Best practices in managing […]

20-20 Interactive Super Panel — A Changing Clinical Landscape: The Future is Now

April 23, 2020

Register now Kick off your virtual DIA experience with a unique opportunity to engage with 20 of the industry’s most influential thought leaders who will give voice to the shifts that are impacting the clinical ecosystem now and their predictions on what the future holds. This dynamic two-hour virtual panel gives you the opportunity to […]

Trial Transformation: A Discussion with Sites on Improving Patient Outcomes with Digital Technology

April 23, 2020

Register Now In the current environment, amid the wake of COVID-19, there is an anticipated but significant increase in demand for virtual or hybrid trials with remote/centralized site monitoring and patient enablement services. With sites increasingly proving to be inaccessible across the globe for patients, site staff and/or site monitors, and regulators halting inspections, the […]

Pharma’s New Normal: Engaging with HCPs in Uncertain Times

April 23, 2020

Register now Face-to-face interactions between pharmaceutical companies and HCPs ceased overnight in the face of the COVID-19 pandemic. Amid this crisis, we had to quickly adjust to a new norm of interpersonal relationships. Join Avant Healthcare for an enlightening conversation with Dr. Chris Bojrab, board-certified psychiatrist and Distinguished Fellow of the American Psychiatric Association, as […]

(APAC Session) Transitioning Clinical Studies from Traditional to Decentralized: An Operational and Regulatory Perspective

April 17, 2020

Register Now Given the unprecedented global health situation, we are seeing a swift change in attitude towards Decentralized Clinical Trials (DCTs) – both fully virtual and hybrid approaches. This is particularly true from a regulatory perspective, where new guidance is coming out with a number of agencies proactively stating their preference for a DCT approach […]

Transitioning Clinical Studies from Traditional to Decentralized: An Operational and Regulatory Perspective

April 15, 2020

Register Now Given the unprecedented global health situation, we are seeing a swift change in attitude towards Decentralized Clinical Trials (DCTs) – both fully virtual and hybrid approaches. This is particularly true from a regulatory perspective, where new guidance is coming out with a number of agencies proactively stating their preference for a DCT approach […]

(APAC Session) Beyond COVID-19: The New Normal in Risk Based Monitoring and Quality Management

April 14, 2020

View OnDemand Now Please join this webinar to learn first-hand how the Parexel and CluePoints partnership is driving best in class Risk-Based Quality Management strategies to support clinical development.  This session will focus on how early risk detection can be leveraged to detect issues across your trial and ensure operational excellence. As the COVID-19 pandemic […]

The Increasing Importance of Patient Adherence and Real Patient Connections Amidst COVID-19

April 13, 2020

Register Now Between the limited interaction with their healthcare provider and the increasing number of health questions, patients are feeling the tremendous burden of added stress as a result of the COVID-19 pandemic. The current situation has already contributed and will continue to contribute to a negative impact on patient adherence and compliance to life-critical […]

Beyond COVID-19: The New Normal in Risk Based Monitoring and Quality Management

April 13, 2020

Register Now Please join this webinar to learn first-hand how the Parexel and CluePoints partnership is driving best in class Risk-Based Quality Management strategies to support clinical development.  This session will focus on how early risk detection can be leveraged to detect issues across your trial and ensure operational excellence. As the COVID-19 pandemic continues, […]

Today’s Tech and Insights-Enabled Patient Support

April 10, 2020

Register Now Technology is changing what patients and HCPs expect from care – from telemedicine, to online portals, to the use of texting and virtual assistants to manage medication adherence. But technology doesn’t stop there. What does a fully tech-enabled patient support experience look like? With a myriad of options from AI, automation, chatbots and […]

Education that Inspires Action: Align Your Communications Programs with Physician Needs

April 4, 2020

Register Now As we adjust to communication without personal interaction, it’s more difficult than ever to engage healthcare providers. When you do get an opportunity to interact with a physician, are you doing everything you can to engage and deliver your message in a way that will be retained? Physicians want and need education from […]

Agile Drug Development Required in a New Age of Urgency

March 17, 2020

Viruses now travel at the speed of sound across the world. Viruses don’t recognize borders. Viruses with no approved treatments will continue to impact thousands of people globally. To protect humanity from the next pandemic, the current paradigm of drug development, clinical trials, and regulatory approvals requires the medical community, life-sciences industry, health institutions, government […]

Boost Your Competitive Advantage with Claims Data

January 22, 2020

The pharma & medical device industry is fiercely competitive. Thousands of companies are launching new drugs and state-of-the-art medical devices on regular basis, vying for the attention of the key physicians that need them, including your company. But you can get ahead of the competition through acting on the available market intelligence today. Join LexisNexis […]

Selecting and implementing mobile sensors to collect clinical trial endpoint data

December 10, 2019

Today, less than 15% of clinical trials capture data from mobile sensors. In many cases these data are used to derive exploratory endpoints, but in some cases they are being used for primary or secondary endpoints. Mobile sensors collect data that can measure aspects of health and function which are difficult to assess by other […]

Understanding the Interplay Between Medicaid and 340B

October 28, 2019

Gain an Understanding of the Complexities of the 340B Program—and Learn Key Findings from Manatt’s 50-State Survey on the Interplay Between the 340B and Medicaid Programs.  The 340B drug discount program—which requires drug manufacturers to provide outpatient drugs to eligible healthcare entities at sharply reduced prices—continues to expand, with the number of participating covered entities […]

Pharma’s Digital Disruptor: How virtual trials are transforming the clinical research experience

October 2, 2019

Virtual Trial models bring clinical research directly to patients to reduce burdens and improve engagement. These innovative models offer operational flexibility to better meet the unique needs of a trial and its key stakeholders. In this webinar, we will discuss: * How early adopter studies are applying virtual trial models in different ways to achieve […]

Best Practices for Launching a Successful and Compliant Clinical Nurse Educator Program

September 17, 2019

Starting a new or complex therapy isn’t easy. Often, patients’ #1 concern is understanding the side effects of their medication and how it may impact their daily life. The need for patient support is greater than ever, but it’s how you provide that support that can make the difference. This webinar will dive deeper into […]

Digital Health: Disruptive Technology or Just a Disruption?

September 16, 2019

Digital technology is redefining every segment of healthcare—from drug discovery and clinical trials to patient treatment and monitoring.  Healthcare, biotechnology and pharmaceuticals all make the top-five list of industries facing the greatest digital disruption over the next three years.  What are the full implications of the digital revolution for life sciences companies? How are business […]

RWE in an Evolving Regulatory Landscape: Using Real-World Evidence to Support Novel Product Development Pathways

August 27, 2019

The growing interest in RWE from both regulators and payors, along with innovative data models and technologies, has the potential to transform clinical research as we know it. Particularly for rare diseases, the opportunity to utilize existing data and to link patients across multiple datasets, in concert with proven prospective research models within non-traditional infrastructure […]

Promotional Review Best Practices: Mitigating Risks, Maximizing Success

August 12, 2019

Discover How to Meet Commercial Goals While Complying with FDA and FTC Regulations. The promotional review process requires a critical balance between ensuring materials achieve business goals and complying with regulatory constraints. There often can be friction on the promotional review committee (PRC) between the marketing team and participants representing medical, legal and regulatory issues. […]

Save Time and Reduce Costs in Procurement and Outsourcing Using Technology

August 6, 2019

Exploring ways to use technology and structured information to evaluate potential business partners, create projects, solicit bids, provide proposal process feedback, and ultimately making the procurement and outsourcing process better for everyone involved. This event will provide valuable insights for companies looking to procure or outsource services as well as companies providing those services. Be […]

Medical Storytelling Through Data: More Than Just Information Transfer

May 15, 2019

This webinar will cover the following objectives. 1. Recognize the boundaries—in addition to knowledge—that shape and change HCP behaviors 2. Identify new strategic frameworks that can help drive your future medical education plans 3. Measure, evaluate, and refine your medical education tactics to ensure they meet your strategic objectives Who Should Attend? Marketing Management Product […]

Machine Learning for Patient Forecasting and Site Selection

April 26, 2019

The clinical development marketplace continues to become more complex and competitive, with stricter regulatory standards and trial oversight—all the while demanding patient-centric drug development.  These, and other factors, contribute to  unsustainable costs and longer timelines before much-needed therapies reach the market.  As the industry looks to technology to drive efficiencies and reduce costs—machine learning continually […]

Improving Clinical Trial Milestones and Reducing Site Burden with Clinical Trial Nurse Educators

April 9, 2019

The growing complexity of clinical trials—with intensified regulatory standards and the need to enroll highly segmented patient populations—causes delays in as many as 90% of trials. With the enormous growth in the development of specialty medicines today, manufacturers have an opportunity to utilize higher-touch, more patient-centric training initiatives in trial protocols to ensure that investigators […]

Transform Teams, Programs, and Services: An experience strategy primer to reset your focus and accelerate business objectives

April 1, 2019

As the pharmaceutical industry moves beyond the pill and seeks opportunities to deliver more novel, sustainable value to customers and patients, human-centered design becomes more relevant to research, patient advocacy, and market access teams than ever. To this end, customer and patient engagement strategies grounded in service design methods become uniquely powerful aids for navigating […]

Reaching for 99% compliance and engagement in clinical trials

March 20, 2019

Patient engagement and participation rates drive the speed and cost of clinical trials. Improving compliance and retention reduces costs, improves data quality, achieves earlier study-lock, and reduces costly failures. Initial industry efforts with modern mobile digital tools suggest that dramatic improvements in compliance and retention are possible. Still, despite some notable examples, we also see […]

Designing and Measuring Engagement in Behavior Change Interventions

January 15, 2019

Engagement is a prerequisite to any successful behavior change intervention, but engagement alone doesn’t guarantee a beneficial outcome. If we want to improve outcomes by improving engagement, we need a clear understanding of what characterizes meaningful engagement, how to design for it, and how to measure it. Despite designers’ every effort to convince, entice, seduce, […]

Building a Secure, Automated Quality System to Accelerate Time to Market

September 17, 2018

Today life science companies face a perfect storm of factors driving their costs up and sales down. With 40% of R&D costs linked to paper-based processes, legacy, manual processes pose a particular threat – costing life science companies billions of dollars a year and delaying product launch and commercialization*. Boston Scientific is tackling these challenges […]

FEEDBACK